MedTrace Logo

Global Anticoagulant Registry in the Field

NCT01090362 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 57250

Last updated 2021-04-28

No results posted yet for this study

Summary

The Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF Registry) is a non-interventional, observational study that characterized a global population of non-valvular atrial fibrillation patients. The registry was used to document global baseline characteristics, current treatment strategies and outcome measures. Characterisation of a number of AF sub-populations was also completed. GARFIELD-AF is an independent academic research initiative sponsored by the Thrombosis Research Institute (London, UK) and supported by an unrestricted research grant from Bayer AG (Berlin, Germany).

Conditions

Sponsors & Collaborators

  • Bayer

    collaborator INDUSTRY

  • University of Birmingham

    collaborator OTHER

  • Brigham and Women's Hospital

    collaborator OTHER

  • Quintiles, Inc.

    collaborator INDUSTRY

  • Advanced Drug and Device Services SAS

    collaborator UNKNOWN

  • Apothecaries Clinical Research

    collaborator UNKNOWN

  • Thrombosis Research Institute

    lead OTHER

Principal Investigators

  • Ajay K Kakkar · Thrombosis Research Institute, London, UK

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-12-21
Primary Completion
2019-06-16
Completion
2020-05-18

Countries

  • United States
  • Argentina
  • Australia
  • Austria
  • Belgium
  • Brazil
  • Canada
  • Chile
  • China
  • Czechia
  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Hungary
  • India
  • Italy
  • Japan
  • Mexico
  • Netherlands
  • Norway
  • Poland
  • Russia
  • Singapore
  • South Africa
  • South Korea
  • Spain
  • Sweden
  • Switzerland
  • Thailand
  • Turkey (Türkiye)
  • Ukraine
  • United Arab Emirates
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01090362 on ClinicalTrials.gov